Thrombolytic therapy for acute pulmonary embolism

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 4, 2013, Pages 452-458

  Tapson, Victor F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

catheter based embolectomy; deep venous thrombosis; pulmonary embolism; right ventricular function; thrombolytic therapy

Indexed keywords

ALTEPLASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; FONDAPARINUX; HEPARIN; RETEPLASE; RIVAROXABAN; STREPTOKINASE; TENECTEPLASE; TROPONIN I; TROPONIN T; UROKINASE;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EMBOLECTOMY; HEART VENTRICLE FUNCTION; HUMAN; LUNG EMBOLISM; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; HUMANS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 84878310798     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1334145     Document Type: Article

References (46)

1. The Urokinase Pulmonary Embolism Trial. A national cooperative study. Circulation: 1973; 47 2 (Suppl): II1 II108
2. Tibbutt D. A., Davies J. A., Anderson J. A., et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. BMJ: 1974; 1 5904 343 347
3. Ly B., Arnesen H., Eie H., Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand: 1978; 203 6 465 470 (Pubitemid 8358211)
4. Dotter C. T., Seamon A. J., Rosch J., et al. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized clinical trial. Vasc Surg: 1979; 13 42 52 (Pubitemid 9170443)
5. Marini C., Di Ricco G., Rossi G., Rindi M., Palla R., Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration: 1988; 54 3 162 173
6. Levine M., Hirsh J., Weitz J., et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest: 1990; 98 6 1473 1479
7. The PIOPED Investigators Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest: 1990; 97 3 528 533
8. Dalla-Volta S., Palla A., Santolicandro A., et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol: 1992; 20 3 520 526
9. Goldhaber S. Z., Haire W. D., Feldstein M. L., et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet: 1993; 341 8844 507 511 (Pubitemid 23066083)
10. Jerjes-Sanchez C., Ramírez-Rivera A., Arriaga-Nava R., et al. de Lourdes García M Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis: 1995; 2 3 227 229
11. Konstantinides S., Geibel A., Heusel G., Heinrich F., Kasper W. Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med: 2002; 347 15 1143 1150
12. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet: 1994; 343 8893 311 322
13. Kearon C., Akl E. A., Comerota A. J., et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 e419S
14. Jaff M. R., McMurtry M. S., Archer S. L., et al. American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation: 2011; 123 16 1788 1830
15. Thabut G., Thabut D., Myers R. P., et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol: 2002; 40 9 1660 1667 (Pubitemid 35253645)
16. Goldhaber S. Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet: 1999; 353 9162 1386 1389 (Pubitemid 29192409)
17. Dong B., Jirong Y., Liu G., Wang Q., Wu T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev: 2006; 2 CD004437
18. Jiménez D., Aujesky D., Moores L., et al. RIETE Investigators Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med: 2010; 170 15 1383 1389
19. Wan S., Quinlan D. J., Agnelli G., Eikelboom J. W. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation: 2004; 110 6 744 749 (Pubitemid 39056276)
20. Lu M. T., Cai T., Ersoy H., et al. Interval increase in right-left ventricular diameter ratios at CT as a predictor of 30-day mortality after acute pulmonary embolism: initial experience. Radiology: 2008; 246 1 281 287 (Pubitemid 350305054)
21. Vedovati M. C., Becattini C., Agnelli G., et al. Multidetector computed tomography for acute pulmonary embolism: Embolic burden and clinical outcome. Chest: 2012; 142 6 1417 1424
22. Kostrubiec M., Pruszczyk P., Bochowicz A., et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J: 2005; 26 20 2166 2172 (Pubitemid 41408001)
23. Becattini C., Vedovati M. C., Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation: 2007; 116 4 427 433 (Pubitemid 47196548)
24. Cavallazzi R., Nair A., Vasu T., Marik P. E. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med: 2008; 34 12 2147 2156
25. Reichlin T., Hochholzer W., Bassetti S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med: 2009; 361 9 858 867
26. Lankeit M., Friesen D., Aschoff J., et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J: 2010; 31 15 1836 1844
27. Lankeit M., Jiménez D., Kostrubiec M., et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation: 2011; 124 24 2716 2724
28. Jiménez D., Aujesky D., Moores L., et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax: 2011; 66 1 75 81
29. Jiménez D., et al. Prognostic significance of deep venous thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med: 2010; 18 983 991
30. Konstantinides S., Tiede N., Geibel A., Olschewski M., Just H., Kasper W. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol: 1998; 82 8 966 970 (Pubitemid 28480783)
31. PEITHO pulmonary embolism thrombolysis study. Available at: http://clinicaltrials.gov/ct2/show/NCT00639743. Accessed January 12, 2013
32. Becattini C., Agnelli G., Salvi A., et al. TIPES Study Group Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res: 2010; 125 3 e82 e86
33. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet: 2001; 358 9282 605 613
34. Kilic A., Shah A. S., Conte J. V., Yuh D. D. Nationwide outcomes of surgical embolectomy for acute pulmonary embolism. J Thorac Cardiovasc Surg: 2013; 145 2 373 377
35. Kuo W. T., Gould M. K., Louie J. D., Rosenberg J. K., Sze D. Y., Hofmann L. V. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol: 2009; 20 11 1431 1440
36. Leacche M., Unic D., Goldhaber S. Z., et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg: 2005; 129 5 1018 1023 (Pubitemid 40631421)
37. Tapson V. F., Gurbel P. A., Witty L. A., Pieper K. S., Stack R. S. Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapy. Chest: 1994; 106 5 1558 1562 (Pubitemid 24346126)
38. Tapson V. F. Interventional therapies for venous thromboembolism: vena caval interruption, surgical embolectomy, and catheter-directed interventions. Clin Chest Med: 2010; 31 4 771 781
39. Greenfield L. J., Kimmell G. O., McCurdy W. C. III. Transvenous removal of pulmonary emboli by vacuum-cup catheter technique. J Surg Res: 1969; 9 6 347 352
40. Siablis D., Karnabatidis D., Katsanos K., Kagadis G. C., Zabakis P., Hahalis G. AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: a retrospective data analysis. J Endovasc Ther: 2005; 12 2 206 214 (Pubitemid 40517055)
41. Margheri M., Vittori G., Vecchio S., et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am J Cardiol: 2008; 101 2 252 258
42. Engelhardt T. C., Taylor A. J., Simprini L. A., Kucher N. Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism. Thromb Res: 2011; 128 2 149 154
43. A prospective, single-arm, multi-center trial of EkoSonic® endovascular system and activase for treatment of acute pulmonary embolism (PE). (SEATTLE II). Available at: http://www.clinicaltrials.gov/ct2/show/NCT01513759. Accessed January 12, 2013
44. Todoran T. M., Sobieszczyk P. S., Levy M. S., et al. Percutaneous extraction of right atrial mass using the Angiovac aspiration system. J Vasc Interv Radiol: 2011; 22 9 1345 1347
45. Stein P. D., Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med: 2012; 125 5 465 470
46. Tapson V. F. What will it take to initiate a move toward a more aggressive therapeutic approach to venous thromboembolism? Am J Med: 2008; 121 11 (Suppl 1): S20 S27